WebUnfractionated heparin (UFH) does not effectively inhibit clot-bound thrombin and increases platelet reactivity, expression of P-selectin and inflammatory responses. These negative effects of UFH cannot be entirely overcome by the addition of a glycoprotein antagonist and may help explain the REPLAC … WebThese phenotypes are associated with Arthritis or its descendants. A phenotype has an inferred association via a curated chemical interaction or a gene-GO annotation or both.
Bivalirudin: pharmacology and clinical applications - PubMed
Web13 mar 2001 · Abstract —Clinical applications for recombinant hirudins have been investigated for the past 10 years. The first indication for which a hirudin—lepirudin—has been approved is treatment of heparin-induced thrombocytopenia (HIT). Also, the recently completed trials for use of lepirudin in unstable angina indicate a potentially new indication. Web13 mar 2001 · Abstract —Clinical applications for recombinant hirudins have been investigated for the past 10 years. The first indication for which a hirudin—lepirudin—has … no doubt 意味 スラング
Recombinant Hirudin - an overview ScienceDirect Topics
Web16 apr 2024 · Despite HLF1 has no antithrombotic activity in previous studies, Muller et al. found that similar thrombin-inhibiting activity to hirudins could be observed in HLF1 after N-terminal modification. Additionally, analogous phenomena could be found in HLF3 and HLF4 through modifications within the N-termini in combination with an exchange of the central … WebBackground: The immunological type of heparin-induced thrombocytopenia (HIT) is the most frequent drug-induced thrombocytopenia. This study evaluated the efficacy of … Web9 ott 2006 · Therefore, hirudins have been successfully used in patients with HIT II and in patients with cell-mediated reactions to heparins. Immediate hypersensitivity reactions to hirudin In a recent postmarketing surveillance of lepirudin in 35 000 patients, the risk of anaphylaxis was 0.015% (five of 32 500) on first exposure and 0.16% (four of 2500) in re … agora telenet